AMP Comments at FDA Meeting on Next Generation Sequencing
Thursday, June 23, 2011 - 06:30
in Mathematics & Economics
The Association for Molecular Pathology (AMP) gave public comments at the US Food and Drug Administration's (FDA) meeting on next generation sequencing and called on officials to partner with professional associations as they develop a program to evaluate sequencing based diagnostics.